Weighted cumulative incidence for (A) the primary composite outcome of all-cause mortality or worsening heart failure, (B) all-cause mortality, (C) heart failure hospitalization, (D) treatment with intravenous diuretics in outpatient setting, and (E) worsening heart failure under 365-day intention-to-treat follow-up, stratified by sodium–glucose cotransporter 2 inhibitors or sitagliptin initiation.